Pearl S. Huang

6.4k total citations
34 papers, 1.9k citations indexed

About

Pearl S. Huang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pearl S. Huang has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pearl S. Huang's work include Cancer-related Molecular Pathways (10 papers), Microtubule and mitosis dynamics (7 papers) and Virus-based gene therapy research (5 papers). Pearl S. Huang is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Microtubule and mitosis dynamics (7 papers) and Virus-based gene therapy research (5 papers). Pearl S. Huang collaborates with scholars based in United States, United Kingdom and Australia. Pearl S. Huang's co-authors include Denis R. Patrick, Jeffrey R. Jackson, Mohammed M. Dar, Allen Oliff, Hans E. Huber, A Oliff, Paula J. Goodhart, David Heimbrook, Raymond E. Jones and Kathleen Haskell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Pearl S. Huang

33 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pearl S. Huang United States 18 1.2k 832 465 226 217 34 1.9k
Rozita Bagheri‐Yarmand United States 23 1.5k 1.2× 780 0.9× 394 0.8× 292 1.3× 304 1.4× 45 2.0k
Weikang Tao China 19 1.5k 1.3× 1.0k 1.2× 360 0.8× 230 1.0× 110 0.5× 43 2.1k
Catherine A. Burkhart United States 16 1.1k 1.0× 775 0.9× 544 1.2× 259 1.1× 89 0.4× 22 1.8k
Julie M. Bailis United States 21 1.5k 1.2× 788 0.9× 299 0.6× 273 1.2× 122 0.6× 55 2.0k
Keith Mikule United States 15 999 0.8× 782 0.9× 518 1.1× 197 0.9× 187 0.9× 29 1.7k
Lee Jamieson United States 17 1.6k 1.4× 490 0.6× 385 0.8× 244 1.1× 110 0.5× 21 2.2k
Ben Hodgson United Kingdom 12 2.0k 1.7× 688 0.8× 401 0.9× 333 1.5× 256 1.2× 13 2.4k
Susan Wee United States 16 2.1k 1.8× 702 0.8× 255 0.5× 295 1.3× 124 0.6× 27 2.6k
Rina Plattner United States 24 1.1k 0.9× 452 0.5× 260 0.6× 170 0.8× 269 1.2× 39 1.9k
Denis R. Patrick United States 18 927 0.8× 708 0.9× 536 1.2× 108 0.5× 203 0.9× 25 1.6k

Countries citing papers authored by Pearl S. Huang

Since Specialization
Citations

This map shows the geographic impact of Pearl S. Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pearl S. Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pearl S. Huang more than expected).

Fields of papers citing papers by Pearl S. Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pearl S. Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pearl S. Huang. The network helps show where Pearl S. Huang may publish in the future.

Co-authorship network of co-authors of Pearl S. Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Pearl S. Huang. A scholar is included among the top collaborators of Pearl S. Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pearl S. Huang. Pearl S. Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Hongyue, Shan Lou, Yanbo Zhang, et al.. (2021). Transcriptional neural‐like signaling contributes to an immune‐suppressive tumor microenvironment. FASEB BioAdvances. 4(1). 76–89. 3 indexed citations
2.
Hondermarck, Hubert, Pearl S. Huang, & John A. Wagner. (2021). The nervous system: Orchestra conductor in cancer, regeneration, inflammation and immunity. FASEB BioAdvances. 3(11). 944–952. 6 indexed citations
3.
Godin, Stephen K., et al.. (2021). The role of peripheral nerve signaling in endometriosis. FASEB BioAdvances. 3(10). 802–813. 17 indexed citations
4.
Zhu, Eric, Daniël Blom, Shalini Sethumadhavan, et al.. (2020). 683 A novel mechanism of neuropilin-1 inhibition results in improved tumor growth inhibition in vivo. SHILAP Revista de lepidopterología. A410.1–A410. 1 indexed citations
5.
Ponz‐Sarvisé, Mariano, Vincenzo Corbo, Hervé Tiriac, et al.. (2019). Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Clinical Cancer Research. 25(22). 6742–6755. 41 indexed citations
6.
Huang, Pearl S., Peter Ho, & Kang Zhang. (2011). A proposal: a comprehensive platform to characterize tumors in Chinese and improve success in cancer drug discovery and development. Chinese Journal of Cancer. 30(6). 363–367.
7.
Luo, Lusong, Cynthia A. Parrish, Neysa Nevins, et al.. (2007). ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism. Nature Chemical Biology. 3(11). 722–726. 92 indexed citations
8.
Jackson, Jeffrey R., Denis R. Patrick, Mohammed M. Dar, & Pearl S. Huang. (2007). Targeted anti-mitotic therapies: can we improve on tubulin agents?. Nature reviews. Cancer. 7(2). 107–117. 388 indexed citations
9.
Sutton, David, Melody Diamond, Leo F. Faucette, et al.. (2007). Efficacy of GSK461364, a selective Plk1 inhibitor, in human tumor xenograft models. 67. 5388–5388. 4 indexed citations
10.
Sutton, David, Aidan G. Gilmartin, Chiu-Mei Sung, et al.. (2007). A potent and selective inhibitor of the mitotic kinesin CENP-E (GSK923295A), demonstrates a novel mechanism of inhibiting tumor cell proliferation and shows activity against a broad panel of human tumor cell lines in vitro. 6. 5 indexed citations
11.
Jackson, Jeffrey R., Aidan G. Gilmartin, Steven D. Knight, et al.. (2006). A second generation KSP inhibitor, SB-743921, is a highly potent and active therapeutic in preclinical models of cancer. 12. 11 indexed citations
12.
Luo, Lusong, Jeffrey D. Carson, Dashyant Dhanak, et al.. (2004). Mechanism of Inhibition of Human KSP by Monastrol:  Insights from Kinetic Analysis and the Effect of Ionic Strength on KSP Inhibition. Biochemistry. 43(48). 15258–15266. 43 indexed citations
13.
Adams, Jerry L., Pearl S. Huang, & Denis R. Patrick. (2002). A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis. Current Opinion in Chemical Biology. 6(4). 486–492. 48 indexed citations
14.
Huang, Pearl S. & Allen Oliff. (2001). Drug-targeting strategies in cancer therapy. Current Opinion in Genetics & Development. 11(1). 104–110. 62 indexed citations
15.
Huang, Pearl S. & Allen Oliff. (2001). Signaling pathways in apoptosis as potential targets for cancer therapy. Trends in Cell Biology. 11(8). 343–348. 58 indexed citations
16.
Huang, Pearl S. & David Heimbrook. (1997). Oncogene products as therapeutic targets for cancer. Current Opinion in Oncology. 9(1). 94–100. 16 indexed citations
17.
Huang, Pearl S., Lenora J. Davis, Hans E. Huber, et al.. (1995). An SH3 domain is required for the mitogenic activity of microinjected phospholipase C‐γ1. FEBS Letters. 358(3). 287–292. 67 indexed citations
18.
Huber, Hans E., Paula J. Goodhart, & Pearl S. Huang. (1994). Retinoblastoma protein reverses DNA bending by transcription factor E2F.. Journal of Biological Chemistry. 269(9). 6999–7005. 34 indexed citations
19.
Huang, Pearl S., Denis R. Patrick, Gwynneth M. Edwards, et al.. (1993). Protein Domains Governing Interactions Between E2F, the Retinoblastoma Gene Product, and Human Papillomavirus type 16 E7 Protein. Molecular and Cellular Biology. 13(2). 953–960. 23 indexed citations
20.
Huber, Hans E., George M. Edwards, Paula J. Goodhart, et al.. (1993). Transcription factor E2F binds DNA as a heterodimer.. Proceedings of the National Academy of Sciences. 90(8). 3525–3529. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rozita Bagheri‐Yarmand Breakdown of academic impact, for papers by Weikang Tao Breakdown of academic impact, for papers by Catherine A. Burkhart Breakdown of academic impact, for papers by Julie M. Bailis Breakdown of academic impact, for papers by Keith Mikule Breakdown of academic impact, for papers by Lee Jamieson Breakdown of academic impact, for papers by Ben Hodgson Breakdown of academic impact, for papers by Susan Wee Breakdown of academic impact, for papers by Rina Plattner Breakdown of academic impact, for papers by Denis R. Patrick
Rankless by CCL
2026